Previous Chapter: B2. Overview and Background: Mechanism of Action of Antiprogestins
Suggested Citation: "B3. The Use of Antiprogestins in the Reproductive Cycle." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 139
Suggested Citation: "B3. The Use of Antiprogestins in the Reproductive Cycle." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 140
Suggested Citation: "B3. The Use of Antiprogestins in the Reproductive Cycle." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 141
Suggested Citation: "B3. The Use of Antiprogestins in the Reproductive Cycle." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 142
Suggested Citation: "B3. The Use of Antiprogestins in the Reproductive Cycle." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 143
Suggested Citation: "B3. The Use of Antiprogestins in the Reproductive Cycle." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 144
Suggested Citation: "B3. The Use of Antiprogestins in the Reproductive Cycle." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 145
Suggested Citation: "B3. The Use of Antiprogestins in the Reproductive Cycle." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 146
Suggested Citation: "B3. The Use of Antiprogestins in the Reproductive Cycle." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 147
Next Chapter: B4. Potential Contraceptive Effects of Antigestogens
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.